For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

p53 protein: guardian of the genome

Related

  • p53 resources
    • Cellular responses of p53
      • Regulation of p53
      • p53 related products
        • p53 sampler panel
          • p53 inhibitors, activators and suppressors
            • p53 proteins and peptides
              • p53 kits

              Here we look at the function, structure, and modifications of p53 and outline the tools you can use to accelerate your p53 research. 

              ​Contents

              • Overview of p53 function and role in cancer 
              • p53 protein structure
              • MDM2 regulation of p53
              • Post-translational modifications of p53
              • p53 sampler panel 
              • References


              Download a pdf version of this guide including additional data

              Overview of p53 function and role in cancer

              p53 is a tumor suppressor protein and transcription factor that regulates cell division and prevents tumor formation by stopping cells with mutated or damaged DNA from dividing and signaling for them to undergo apoptosis through transcriptional regulation. 

              It activates a multitude of transcriptional targets in response to cellular stress or DNA damage. A broad range of of responses are coordinated by p53 including cell cycle arrest, DNA repair, altered metabolism, anti-oxidant effects, anti-angiogenic effects, autophagy, senescence, and apoptosis (Bieging et al., 2014). 

              Cell cycle arrest
              p53 can inhibit cell cycle progression in several ways. One way is through the upregulation of p21 expression. p21 protein will then bind cyclin E/Cdk2 and cyclin D/ Cdk4 resulting in G1 arrest of the cell cycle (Wade-Harper et al., 1993). p53 can also bring about cell cycle arrest at the G2/M phase through binding to other p53 target genes such as 14-3-3σ (Martín-Caballero et al., 2001) and cdc25C (Clair et al., 2004). 

              DNA repair
              ​p53 plays a role in DNA repair through both halting the cell cycle to allow repair machinery to operate and directly through the activation of repair mechanisms (Williams et al., 2016). p53 is commonly referred to as the “guardian of the genome” because it constantly surveys the genome for signs of DNA damage such as double-strand breaks. p53 is also plays an active role in many different types of DNA repair including nucleotide excision repair, base excision repair, mismatch repair, and nonhomologous end-joining (Williams et al., 2016).

              p53 gene mutation and cancer 
              ​TP53 (the gene encoding for p53) is the single most frequently mutated gene in human cancer, with partial or complete loss of function occurring in over 50% of tumors (Perri et al., 2016). Mutations in p53 confer a selective advantage on the tumor cells, allowing them to evade cell cycle checkpoints, avoid apoptosis and senescence, and proliferate under conditions where normal cells cannot (Pascual et al., 2019).

              Download our p53 pathway poster 

              p53 protein structure

              The p53 protein is active as a tetramer of four chains of 393 amino acids. Each chain has several domains. At the N-terminal, there are two distinct transactivation domains (TADI and TADII), a nuclear export signal (NES) followed by the proline-rich domain (PD) and the DNA binding domain (DBD) (Wang et al., 1994).

              The TADI (residues 1–42) and TADII (residues 43–62) are critical for p53 regulation as they provide binding sites for the transcriptional machinery and the negative regulator MDM2. The DBD (residues 102–292) is pivotal for the transcriptional activity of p53. It contains 4 of the 5 conserved boxes in p53. The OD (residues 323–356) allows p53 to form a tetramer which is organized as a dimer of dimers (Khoury et al., 2011).

              At the C-terminus, there is an oligomerization domain (OD), three nuclear localization signals (NLS), a second NES and a lysine-rich regulatory domain (RD). The cluster of three NLSs mediate the nuclear location of the protein by binding to specific receptors to allow selective passage of p53 through the nuclear pore complex.

              The C-terminal NES, a highly conserved region has been shown to be essential for nuclear export of p53. Both the NLS and NES regions are required for nuclear-cytosolic shuttling of p53 to regulate p53 transcriptional function (Inoue et al., 2002).


              MDM2 regulation of p53

              Murine double minute 2 (MDM2), is an E3 ubiquitin ligase responsible for the degradation of p53 in wild type cells. p53 also induces the expression of MDM2, creating a p53/MDM2 feedback loop. Approximately 17% of tumors exhibit mdm2 gene amplification leading to reduced levels and p53 and therefore poor prognosis for patient diagnosis. This makes MDM2-p53 interaction a key target for cancer therapy (Nag et al., 2013). 

              Tools for MDM2 research:


              MDM2
              AntibodyAnti-MDM2 (2A10) antibody

              Anti-MDM2 (phospho S166) antibody

              Post-translational modifications of p53

              When the cell is confronted with stress, p53 ubiquitylation is suppressed and p53 accumulates in the nucleus, where it is activated and stabilized by post-translational modification including phosphorylation and acetylation (Dai et al., 2010).

              Here we focus on some of these post-translational modifications (phosphorylation and acetylation) and their role in p53 stress response. 

              p53 phosphorylation
              ​
              Phosphorylation of p53 occurs rapidly in response to cellular stress. p53 contains multiple serine and threonine residues that serve as phosphorylation sites for protein kinases (Dai et al., 2010). These kinases include ATM/ATR, Chk1/Chk2, CK1, CK2, PKC, CDK1/2, DNA-PK, HIPK2, ERK2, p38, and JNK.​​​

              Tools for p53 phosphorylation research:

              Amino acidRecommended antibodyApplication
              S15Anti-p53 (phospho S15) antibodyIHC-Fr, ICC/IF, IHC-P, WB, IP
              S20Anti-p53 (phospho S20) antibodyWB, IP, Dot blot
              S33Anti-p53 (phospho S33) antibodyDot blot, WB, ICC/IF
              S37Anti-p53 (phospho S37) antibodyDot blot, WB
              S46Anti-p53 (phospho S46) antibodyWB, IP, IHC-P, ICC/IF

              p53 acetylation
              ​p53 is specifically acetylated by p300/CBP and P300/CBP-associated factor (PCAF) in response to gamma-irradiation and UV light, and TIP60 and hMOF in response to DNA damage. Acetylation of p53 augments p53 DNA binding, aids in recruiting co-activators, and stabilizes p53 by inhibiting its ubiquitination by MDM2 (Dai et al., 2010).

              Tools to study p53 acetylation:

              Amino acidRecommended antibodyApplication
              K370Anti-p53 (acetyl K370) antibodyFlow Cyt, ICC/IF, IP, WB
              K373Anti-p53 (acetyl K373) antibodyFlow Cyt, ICC/IF, IHC-P, WB 
              K381Anti-p53 (acetyl K381) antibodyELISA, ICC/IF, IHC-P, WB
              K382Anti-p53 (acetyl K382) antibodyFlow Cyt, ICC/IF, WB


              p53 antibody sampler panel: comprehensive and specific

              Detect a comprehensive range of p53 modifications, as well as total and mutated p53 with our comprehensive antibody sampler panel. This panel contains recombinant monoclonal antibodies for precise specificity and exceptionally low variation between lots. 

              Antibodies in this panel (ab219089) include the following:

              Unmodified p53 mouse monoclonal [DO-1] (ab1101)

              • Knockout validated on CRISPR/Cas9-mediated HAP1 cells
              • Verified for ChIP, ICC/IF, ELISA, IHC-P, IHC-Fr, immunoprecipitation, western blot, flow cytometry
              • Reacts with human p53
              • Cited in over 71 publications

              Recombinant rabbit monoclonal to Mutant p53 [Y5] (ab32049)

              • ​Marker of cancer progression
              • Verified use in ICC/IF, western blot, IHC-P, flow cytometry, immunoprecipitation
              • Tested in human
              • Cited in 29 publications

              Recombinant rabbit monoclonal to p53 (phospho S20) [EPR2156(2)] (ab157454) Phosphorylated p53

              • Verified for use in western blot, immunoprecipitation, and dot blot
              • Tested in human 

              Recombinant rabbit monoclonal to p53 (phospho S46) [EP42Y] (ab76242)

              • Verified use in western blot, immunoprecipitation, IHC-P, ICC/IF
              • Tested in human
              • Cited in 8 publications 

              Recombinant rabbit monoclonal to p53 (phospho S392) [EP155Y] (ab33889)

              • p53 is phosphorylated on Serine 392 following UV irradiation (sans gamma irradiation)
              • Verified use in Dot blot, WB, IHC-P and IP 
              • Tested in human, mouse, and rat
              • Cited in 3 publications

              Recombinant rabbit monoclonal to p53 (acetyl K382) [EPR358(2)] (ab75754)

              • ​Verified use in western blot, ICC/IF and flow cytometry
              • Tested in human
              • Cited in 18 publications


              ​​

              References

              Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014). Unravelling mechanisms of p53-mediated tumour suppression. Nature Reviews Cancer, 14(5), 359–370.

              Clair, S. S., Giono, L., Varmeh-Ziaie, S., Resnick-Silverman, L., Liu, W. J., Padi, A., … Manfredi, J. J. (2004). DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: One involves direct binding to the cdc25C promoter. Molecular Cell, 16(5), 725–736.

              Dai, C., & Gu, W. (2010). P53 post-translational modification: Deregulated in tumorigenesis. Trends in Molecular Medicine, 16(11), 528–536.

              Inoue, T., Stuart, J., Leno, R., & Maki, C. G. (2002). Nuclear import and export signals in control of the p53-related protein p73. Journal of Biological Chemistry, 277(17), 15053–15060.

              Khoury, M. P., & Bourdon, J. C. (2011). P53 isoforms: An intracellular microprocessor? Genes and Cancer, 2(4), 453–465.

              Martín-Caballero, J., Flores, J. M., García-Palencia, P., & Serrano, M. (2001). Tumor Susceptibility of p21 Waf1/Cip1-deficient Mice 1. Cancer Research, 61, 6234–6238.

              Nag, S., Qin, J., Srivenugopal, K. S., Wang, M., & Zhang, R. (2013). The MDM2-p53 pathway revisited. Journal of Biomedical Research, 27(4), 254–271.

              Pascual, M., Mena-Varas, M., Robles, E. F., Garcia-Barchino, M. J., Panizo, C., Hervas-Stubbs, S., … Roa, S. (2019). PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas. In Blood (Vol. 133).

              Perri, F., Pisconti, S., & Vittoria Scarpati, G. Della. (2016). P53 mutations and cancer: A tight linkage. Annals of Translational Medicine, 4(24), 2–5.

              Wade Harper, J., Adami, G. R., Wei, N., Keyomarsi, K., & Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75(4), 805–816. 

              Wang, P., Reed, M., Wang, Y., Mayr, G., Stenger, J. E., Anderson, M. E., … Tegtmeyer, P. (1994). P53 Domains: Structure, Oligomerization, and Transformation. Molecular and Cellular Biology, 14(8), 5182–5191.

              Williams, A. B., & Schumacher, B. (2016). p53 in the DNA-damage-repair process. Cold Spring Harbor Perspectives in Medicine, 6(5), 1–16. 

              Get resources and offers direct to your inbox Sign up
              A-Z by research area
              • Cancer
              • Cardiovascular
              • Cell biology
              • Developmental biology
              • Epigenetics & Nuclear signaling
              • Immunology
              • Metabolism
              • Microbiology
              • Neuroscience
              • Signal transduction
              • Stem cells
              A-Z by product type
              • Primary antibodies
              • Secondary antibodies
              • Biochemicals
              • Isotype controls
              • Flow cytometry multi-color selector
              • Kits
              • Loading controls
              • Lysates
              • Peptides
              • Proteins
              • Slides
              • Tags and cell markers
              • Tools & Reagents
              Help & support
              • Support
              • Make an Inquiry
              • Protocols & troubleshooting
              • Placing an order
              • RabMAb products
              • Biochemical product FAQs
              • Training
              • Browse by Target
              Company
              • Corporate site
              • Investor relations
              • Company news
              • Careers
              • About us
              • Blog
              Events
              • Tradeshows
              • Conferences
              International websites
              • abcam.cn
              • abcam.co.jp

              Join with us

              • LinkedIn
              • facebook
              • Twitter
              • YouTube
              • Terms of sale
              • Website terms of use
              • Cookie policy
              • Privacy policy
              • Legal
              • Modern slavery statement
              © 1998-2023 Abcam plc. All rights reserved.